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To test whether amino acid mutations in the PBC and PHI loops of VP2 are involved in the replication and virulence of infec-
tious bursal disease virus (IBDV), a pair of viruses, namely the moderately virulent IBDV (rGx-F9VP2) and the attenuated 
strain (rGt), were used. Residue mutations A222P (PBC) and S330R (PHI), selected by sequence comparison, were introduced 
individually into rGx-F9VP2 by using a reverse genetics system. In addition, the reverse mutation of either P222A or R330S 
was introduced into rGt. The four modified viruses were then rescued and evaluated in vitro (CEF cells) and in vivo (SPF 
chickens). Results showed that A222P elevated the replication efficiency of rGx-F9VP2 while P222A reduced that of rGt in 
CEF cells. A mutation at residue 330 did not alter IBDV replication. In addition, animal experiments showed that a single mu-
tation at either residue 222 or 330 did not significantly influence the virulence of IBDV. In conclusion, residue 222 in PBC of 
VP2 is involved in the replication efficiency of IBDV in vitro but does not affect its virulence in vivo, further facilitating our 
understanding of the gene-function of IBDV. 
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Infectious bursal disease virus (IBDV) is the causative agent 
of a highly contagious disease in chickens known as infec-
tious bursal disease (IBD). IBD causes significant losses of 
the poultry industry owing to its high mortality and immu-
nosuppression in young chickens via the destruction of de-
veloping B lymphocytes in the bursa (Cosgrove, 1962; 
Muller et al., 2003). IBDV belongs to the Birnaviridae fam-
ily and has a genome that consists of two segments of dou-
ble-stranded RNA (segments A and B). Segment B encodes 
the VP1 protein, the viral RNA-dependent RNA polymerase 
(Le Nouen et al., 2006; von Einem et al., 2004), while seg-
ment A contains two partially overlapping open reading 
frames (ORF). The smaller ORF encodes the non-structural 
protein VP5 (Mundt et al., 1995), while the larger one en-
codes a polyprotein which is cleaved into proteins pVP2, 
VP3, and VP4 (Birghan et al., 2000). VP2 and four peptides 
are further derived from the maturation of pVP2 (Da Costa 
et al., 2002).  
As the sole component of the icosahedral capsid, VP2 is 
folded into three distinct domains, designated the base (B), 
shell (S), and projection (P) (Coulibaly et al., 2005; Garriga 
et al., 2006; Lee et al., 2006). Domains B and S are rela-
tively well conserved, whereas domain P is more variable. 
The tower-like P domain contains four loops, PBC, PHI, PDE, 
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and PFG. It has been reported that the PDE and PFG domains 
are responsible for cell-tropism and virulence (Brandt et al., 
2001; Qi et al., 2009, 2013; van Loon et al., 2002). The oth-
er two loops, PBC and PHI, are also located at the tip of the 
VP2 spike; however, their roles in viral replication and vir-
ulence are not fully understood. 
Previously, a moderately virulent IBDV strain 
(rGx-F9VP2) and an attenuated strain (rGt) were rescued, 
providing a good model system for studying the viral repli-
cation and virulence of IBDV (Qi et al., 2007, 2009, 2013). 
In the current study, specific amino acid mutations in the 
PBC and PHI domains of VP2 were introduced into the 
backbone of the virulent (rGx-F9VP2) and attenuated (rGt) 
strains in order to evaluate the roles of these amino acid 
changes in replication and virulence. 
RESULTS 
Sequence analysis of the PBC and PHI domains of VP2 
Sequence alignment showed that, compared to virulent 
IBDV including rGx-F9VP2, two amino acids mutations, 
one at loop PBC (A222P) and another at loop PHI (S330R), 
were observed in the attenuated strain including Gt (Fig-  
ure 1). 
Rescue and identification of the modified IBDV 
In cells co-transfected with pCGxATA-G794CHRT/ 
pCGxBHRT or pCGxATA-T1120AHRT/pCGxBHRT, the 
modified IBDV rGxHT-222 or rGxHT-330 strains were 
rescued, which contained a single mutation A222P in PBC or 
S330R in PHI of VP2 compared to the virulent strain rGx- 
F9VP2, respectively. In cells co-transfected with pCmG-
tA-C794GHRT/pCmGtBHRT or pCmGtA-A1120THRT/ 
pCmGtBHRT, the modified IBDV rGt-222 or rGt-330 strain 
was rescued, which contained the reverse mutation P222A 
or R330S compared to the attenuated strain rGt. 
Replication characteristics of the modified IBDV 
To investigate the replication character in vitro of the 
modified IBDV strains in detail, a replication kinetics 
curve in CEF cells was depicted (Figure 2). Compared to 
the parental strain of rGx-F9VP2, rGxHT-222 replicated 
more efficiently, where the titers were significantly higher 
than rGx-F9VP2 after 36 h post-infection (p.i.) (P<0.05). 
rGxHT-330 showed a similar curve to rGx-F9VP2 (Figure 
2A). Compared to the rGt parental strain, rGt-222 replicated 
less efficiently in CEF cells after 48 h p.i.. The titer of 
rGt-222 was 106.7 TCID50 mL
−1 at 60 h p.i., which was ten 
times lower than that of rGt (P<0.05) (Figure 2B). rGt-330 
showed a similar curve to rGt (Figure 2B). 
The pathogenicity of the modified IBDV to chicken 
The pathogenicity of the modified IBDV rGxHT-222 and 
rGxHT-330 strains was evaluated using three-week-old SPF 
chickens. Neither death nor clinical symptoms of IBD were 
observed in any of the groups during the experimental peri-
od. In order to investigate the underlying sub-clinical lesion, 
the BBIX at different days p.i. was calculated. The BBIX of 
the rGxHT-330 and rGx-F9VP2 groups were below 0.7 
from 3 d p.i. to 14 d p.i., indicating signs of atrophy. In the 
rGxHT-222 group, a BBIX above 0.7 was observed before 
3 d p.i. and then the BBIX decreased to below 0.7 (Figure 
3A). 
The histopathological changes of the infected bursae are 
presented in Figure 3B. Chickens from all groups, 
rGxHT-222, rGxHT-330, and rGx-F9VP2, showed persis-
tent histopathological bursal lesions, including lymphocytic 
deletion and necrosis, regional atrophy, and fibrosis of the 
follicle (average HBLS was 4). No obvious bursal lesions 
were observed in the DMEM control group (HBLS was 0). 
RT-PCR and sequencing results confirmed that the modi-
fied viruses replicated in the bursae of chickens without 
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Figure 1  Comparison of the amino acid sequences of the PBC (aa 204–237) and PHI domain (aa 305–337) of IBDV VP2 from virulent and attenuated strains. 
The amino acids differences are marked. 
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Figure 2  Replication characteristics of the modified IBDV. Replication 
kinetics curves in vitro of the modified IBDV based on backbone of 
rGx-F9VP2 and rGt strains are shown in (A) and (B), respectively. Aver-
age titers and standard deviations (error bars) from three independent sam-
ples are shown. Treatments sharing different lowercase letters differ sig-
nificantly at a confidence level (P<0.05). 
DISCUSSION 
As an RNA virus, IBDV is genetically prone to mutation. In 
terms of disease control and early warning, it is important to 
fully understand the gene or residue function. Since the de-
velopment of reverse genetics, the role of VP2 in replication 
or virulence has attracted much attention (Brandt et al., 
2001; Li et al., 2015; Qi et al., 2009, 2013; van Loon et al., 
2002). However, the precise molecular determinants are still 
somewhat unclear. The synergistic effects of multi-genes or 
multi-residues are indispensable (Boot et al., 2000; Le 
Nouen et al., 2006), although the virulence and replication 
of many viruses, including IBDV, mostly depend on the 
major corresponding gene. The four loops of VP2, PBC, PHI, 
PDE, and PFG, are located at the outermost surface of IBDV. 
Loops PDE and PFG influence cell-tropism and virulence and 
have been researched in detail (Brandt et al., 2001; Lim et 
al., 1999; Mundt, 1999; Qi et al., 2009, 2013; van Loon et 
al., 2002). While the PBC and PHI residues are unlikely to be 
involved in three-dimensional folding (Letzel et al., 2007), 
mutations at some residues mutations are thought to directly 
or indirectly alter the characteristics of VP2 via different 
mechanisms (Durairaj et al., 2011; Letzel et al., 2007). 
Therefore, we hypothesized that PBC and PHI might contrib-
ute to viral replication or virulence. 
Sequence analysis showed that two conserved residue 
differences, A222P (PBC) and S330R (PHI), were observed in  
 
 
Figure 3  Evaluation of the influence of residue 222 or 330 of VP2 on the virulence of IBDV. A, Kinetics curves of bursa:body-weight index (BBIX) of 
SPF chickens infected with the modified virus. Average titers and standard deviations (error bars) from three independent samples are shown. Treatments 
sharing different lowercase letters differ significantly at a confidence level (P<0.05). B, Histopathological appearance of bursal sections (hematoxylin and 
eosin) derived from groups of chickens infected with the modified viruses. 
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the PBC and PHI domains between virulent and attenuated 
IBDV strains. The virulent IBDV strain rGx-F9VP2 and 
attenuated strain rGt were chosen to verify the hypothesis 
because they have a similar gene background but have dif-
ferent characters. Firstly, A222P (PBC) and S330R (PHI) 
were introduced into the backbone of rGx-F9VP2, and the 
resulting mutated viruses rGxHT-222 and rGxHT-330 were 
rescued. rGt replicated more efficiently in vitro compared 
with rGx-F9VP2. Replication of the mutated viruses was 
then evaluated. In CEF cells, it was clear that A222P of PBC 
could significantly increase the replication of rGx-F9VP2 
while S330R of PHI could not. To further verify these re-
sults, the reverse mutation P222A or R330S was introduced 
into rGt and the rescued virus rGt-222 replicated less effi-
ciently than rGt, while rGt-330 showed similar replicate 
curve to rGt. The data obtained from these different back-
bones verified that residue 222 of PBC in VP2 could defi-
nitely influence the replication efficiency of IBDV in vitro 
but that a mutation in residue 330 could not. 
Residue 222 of VP2 is typically A in vvIBDV and P in 
non-vvIBDV strains. Sometimes, T residue at position 222 
of VP2 has also been observed in a few variant strains, in-
cluding DEL-E, GLS, and GA988 (Jackwood and 
Sommer-Wagner, 2011; Letzel et al., 2007). Recently, a 
new occurring mutation P222S was observed in Belg strain 
(Letzel et al., 2007). A single substitution at position 222 
(P222S or A222T) was able to alter the antigenic pattern of 
IBDV because an S or T residue at position 222 is the es-
sential part of the epitope that reacts with MAb 67 (Letzel et 
al., 2007). Recently, a natural mutation T222A was shown 
to allow the Del-E strain to break through the maternal im-
munity induced by parenteral vaccination (Jackwood and 
Sommer-Wagner, 2011). 
Residue 330 belongs to the heptapeptide-domain (aa 
326-332) that closely follows the major hydrophilic peak B 
(aa 312-324 of VP2). There is usually a conserved amino 
acid difference at residue 330, which is R in attenuated and 
S in non-attenuated strains. Residue 330 had originally been 
thought to influence cell-tropism of IBDV; however, this 
has since been refuted (Brandt et al., 2001; Lim et al., 1999; 
Mundt, 1999). Recently, it was reported that recognition of 
the MAb 57 epitope involves the PHI loop, and specifically a 
residue at position 330 (Letzel et al., 2007). The three-  
dimensional structure shows that residue 330 is located at 
the interface between subunits in the trimeric spike of VP2 
and a mutation here could lead to subtle alterations in the 
jelly roll, ultimately leading to a different conformation of 
loop PBC (Letzel et al., 2007). It is possible that the subtle 
change in the conformation of PBC induced by the residue 
330 mutation is not sufficient to alter the assembly and sta-
bility of the virus such that S330R cannot influence the rep-
lication of IBDV. 
The virulence of rGxHT-222 and rGxHT-330 was further 
evaluated using SPF chickens. As was reported for rGx- 
F9VP2, chickens in both the rGxHT-222 and rGxHT-330 
groups did not present any typical clinical symptoms. To 
further detect the pathological lesions, the BBIX and the 
degree of damage to the bursae were evaluated, parameters 
which have been used in many studies of sub-clinical dis-
ease (Boot et al., 2000; Brandt et al., 2001; Jackwood et al., 
2008; Le Nouen et al., 2006; Liu and Vakharia, 2004; Qi et 
al., 2009; Raue et al., 2004; Rautenschlein et al., 2003). 
Atrophy of the bursa was not found in chicken samples 
from the rGxHT-222 group at 3 d p.i., but rGxHT-222, 
rGxHT-330, and rGx-F9VP2 did cause obvious histopatho-
logical bursal lesions. There is typically a negative correla-
tion between the replication efficiency in cell culture and 
the virulence of IBDV. However, data from the current 
study demonstrate that the A222P mutation elevated the 
viral replication efficiency in vivo but did not obviously 
attenuate rGx-F9VP2. Further studies will be required to 
uncover the molecular mechanism that underlies this effect. 
In conclusion, the current study represents the first 
demonstration that residue 222 in the PBC loop of VP2 is in-
volved in the replication efficiency of IBDV in vitro but does 
not have a role in its virulence in vivo. A mutation at residue 
330 in the PHI loop of VP2 did not contribute to the replica-
tion and virulence of IBDV. These findings are beneficial to 
our further understanding of the gene-function of IBDV. 
MATERIALS AND METHODS 
Viruses, cells, and plasmids 
The rGx-F9VP2 strain of IBDV, which shows moderate 
virulence, was previously rescued and was shown to induce 
severe bursal lesions in chickens but did not cause mortality 
(Qi et al., 2009). The rGt virus was previously rescued from 
the infectious clones of the attenuated strain of Gt and has 
similar characteristics to the parental strain (Qi et al., 2007). 
DF-1 cells were cultured in Dulbecco’s modified eagle me-
dium (DMEM) (Invitrogen, USA) supplemented with 10% 
fetal bovine serum at 37°C in a humidified 5% CO2 incuba-
tor. Chicken embryo fibroblast (CEF) cells were prepared 
from 10-day-old specific-pathogen-free (SPF) chicken em-
bryos. The infectious clones pCmGtAHRT and pCm- 
GtBHRT (containing segments A and B of rGt) (Qi et al., 
2007), and the infectious clones pCGxAF9VP2HRT and 
pCGxBHRT (containing segments A and B of rGx-F9VP2) 
were constructed previously (Qi et al., 2009). 
Animals 
SPF chickens were purchased from the Experimental Ani-
mal Center of the Harbin Veterinary Research Institute 
(HVRI), the Chinese Academy of Agricultural Sciences 
(CAAS), and were housed in negative-pressure-filtered air 
isolators. All animal experiments were approved by the 
Animal Ethics Committee of HVRI. 
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Sequence alignment of the PBC and PHI domains of VP2 
To identify interesting amino acid residue differences, the 
amino acid sequences of the PBC (aa 204 to 237) and PHI (aa 
305 to 337) domains of VP2 of virulent and attenuated 
strains were compared. Virulent strains: D6948 (GenBank 
accession no. AF240686), HK46 (AF092943), UK661 
(X92760), OKYM (D49706), KS (DQ927042), Gx 
(AY444873), HuB-1(KF569805), SD10LY01 (KF569803), 
T09 (AY099456). Attenuated strains: CU1 (X16107), D78 
(AF499929), P2 (X84034), CT (AJ310185), Gt (DQ- 
403248). Alignment based on the amino acid sequences was 
performed using DNAStar (5.01 edition). 
Modification of segment A of IBDV using site-directed 
mutagenesis 
To introduce direct mutations into segment A of the rGx- 
F9VP2 strain, based on the parental pCGxAF9VP2HRT 
plasmid, PCR for site-directed mutagenesis with specific 
primer pairs was performed as described previously (Qi et 
al., 2007). The primer pair GxAG794CU/GxAG794CL or 
GxAT1120AU/GxAT1120AL (Table 1) was synthesized to 
introduce a direct mutation G794C or T1120A (resulting 
in an amino acid mutation A222P or S330R in VP2) into 
segment A of the rGx-F9VP2 strain. The mutated plas-
mid was named pCGxATA-G794CHRT and pCGx-
ATA-T1120AHRT, respectively (Figure 4A). Similarly, to 
Table 1  Primers for genome cloning and mutagenesis of IBDV. 
Name Sequence Orientation Position (nt) 
GxAG794CU CATCACAGTACCAAcCAGGTGGGGTAAC sense A: 780–807 
GxAG794CL GTTACCCCACCTGgTTGGTACTGTGATG antisense A: 780–807 
GxAT1120AU GTCAGCAAGaGGGAGCCTAGCA sense A: 1,111–1,132 
GxAT1120AL TGCTAGGCTCCCtCTTGCTGAC antisense A: 1,111–1,132 
GtAC794GU CATCACAGTACCAAgCAGGTGGGGTAAC sense A: 780–807 
GtAC794GL GTTACCCCACCTGcTTGGTACTGTGATG antisense A: 780–807 
GtAA1120TU GTCGGCAAGtGGGAGCCTAGCA sense A: 1,111–1,132 
GtAA1120TL TGCTAGGCTCCCaCTTGCCGAC antisense A: 1,111–1,132 
GxAU GGAATTCGGATACGATCGGTCTGAC sense A: 1–18 
GxA1477L AGGTAGCCCATGTCTGGT antisense A: 1,460–1,477 
B3P ACTACCCACTCCTGAACAAA sense B: 2,009–2,028 
B37 GCTCTAGAGGGGGCCCCCGCAGGCGAAGGCCGGGGAT antisense B: 2,799–2,827 
 
 
Figure 4  Schematic diagrams of the infectious clones containing the modified cDNAs of segment A of IBDV (not drawn to scale). Mutations were intro-
duced into VP2 of segment A backbone of the virulent strain rGx-F9VP2 (depicted by an open box) (A) or the attenuated strain rGt (depicted by a box with 
dot) (B). The restriction enzyme sites used for the construction of recombinant vectors are also shown. 
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introduce a reverse mutation into segment A of the rGt 
strain, based on the parental plasmid pCmGtAHRT, a 
primer pair GtAC794GU/GtAC794GL or GtAA- 
1120TU/GtAA1120TL (Table 1) was used to introduce 
a nucleotide mutation C794G or A1120T (resulting in 
an amino acid mutation P222A or R330S in VP2) into 
segment A of rGt to obtain the modified plasmids 
pCmGtA-C794GHRT and pCmGtA-A1120THRT, re-
spectively (Figure 4B). 
Rescue and identification of modified IBDV 
Using the reverse genetics system directed by RNA poly-
merase II, virus rescue was performed as previously de-
scribed (Qi et al., 2007). The purified plasmids with the 
rGx-F9VP2 backbone (pCGxATA-G794CHRT or pCGx-
ATA-T1120AHRT) were co-transfected with pCGxBHRT 
into DF-1 cells. The purified plasmids with the rGt back-
bone (pCmGtA-C794GHRT or pCmGtA-A1120THRT) 
were co-transfected with pCmGtBHRT into DF-1 cells. 
Three days post-transfection, the cell cultures were freeze- 
thawed three times and the supernatants were transferred to 
fresh CEF cells. The viruses were harvested from the in-
fected cell cultures when a visible cytopathic effect (CPE) 
was apparent. The modified viruses were blind-passaged six 
times in CEF cells prior to subsequent experiments. To 
characterize the modified viruses, an indirect immunofluo-
rescence assay (IFA) with an anti-VP2 mAb, an electron 
microscopy assay, RT-PCR, and sequencing using the 
primer pairs GxAU/GxA1477L and B3P/B37 (Table 1) 
were performed as previously described (Qi et al., 2007). 
Replication of modified IBDV in vitro 
To assess the replication abilities of the modified viruses 
and the control strain rGx-F9VP2 or rGt, confluent second-
ary CEF cells in 60 mm culture plates (approximately 106 
cells/plate) were infected with each virus strain at a 50% 
cell culture infective dose (TCID50) of 1×10
4 and were sub-
sequently harvested at 24, 36, 48, 60, and 72 h p.i.. The titer 
of the infectious viral progeny was determined as TCID50 
per milliliter using the Reed-Muench formula (Reed and 
Muench, 1938). The mean values and standard deviations of 
the data obtained from three independent experiments were 
calculated. 
Animal experiments 
Three-week-old SPF chickens were randomly divided into 
four groups (eighteen chickens per group). Chickens were 
inoculated via ocular and intranasal routes with 105.8 
TCID50 of rGxHT-222, rGxHT-330, and rGX-F9VP2. 
DMEM was used as a negative control. Chickens were ob-
served daily for signs of clinical symptoms. At 2, 3, 5, 7, 
10, and 14 d p.i., three chickens were randomly selected 
from each group, euthanized for necropsy, and examined 
for signs of pathological changes. The bursa:body-weight 
index (BBIX) was calculated with standard deviation 
(BBIX=(bursa:body-weight ratios)/(bursa:body-weight 
ratios in the negative group)). The mean values and standard 
deviations of the data obtained from three independent 
chicken samples were calculated. Bursa with a BBIX lower 
than 0.7 were considered atrophied (Lucio and Hitchner, 
1979). Each bursa was then divided into two parts, one for a 
histopathological assay and the other for detecting the viral 
gene. 
Histopathology 
Bursae from each group isolated on different days p.i. were 
fixed immediately after necropsy in 10% neutral buffered 
formalin and were stained with hematoxylin and eosin for 
histopathological examination, as described previously (Qi 
et al., 2009). The severity of bursal follicular necrosis was 
recorded using the average histopathologic bursa lesion 
score (HBLS) system, as described earlier (Schroder et al., 
2000). 
Statistical analyses 
One-way ANOVA was used to evaluate the significant dif-
ferences among the different groups. P<0.05 was consid-
ered a significant difference. 
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